China-India joint summit discusses bilateral trade to improve pharma industry
The China-India joint summit held recently discussed bilateral trade to improve Indo- China pharma industry and address issues like long product registration time and high fees for product registration in China’s drug regulatory system, among other issues. Besides this, other relevant key issues related to transparency in public procurement system in China and clinical trial related approvals were also deliberated at the summit organised under the aegis of Indian Pharmaceutical Association (IPA), Shengjie and SaSPinjara, China between May 16 and May 17, 2019 at Pullman Shanghai South, China. The summit was focused on enhancing export business for both the nations across the globe. Senior health ministry official from Government of Gujarat Punamchand Parmar was invited as the Chief Guest of the summit and Gujarat Food and Drugs Control Administration (FDCA) Commissioner Dr Hemant Koshia was invited as Guest of Honour. Among other dignitaries, Dr. Anil Kumar Rai, Consulate Ge...
This blog gives very important info about SAS and pharma Thanks for sharing.Very well written information. Many thanks.
ReplyDeleteSAS training
SAS course
SAS Certification
SAS Certification course
Online SAS Training
Online Pharmacovigilance course
class room pharmacovilance training
It is important for clinical SAS training in Hyderabad from IGCP who want to make their career in data analysis.
ReplyDeleteSelecting the best clinical SAS training institute in Hyderabad requires considering several factors to ensure you receive high-quality education and support for your career in clinical research and data analysis.
ReplyDelete